Treatment of Neovascular Age-Related Macular Degeneration with Anti-VEGF Agents: Predictive Factors of Long-Term Visual Outcomes

Figure 3

Predictive variables of best-corrected visual acuity variation at 60 months. (a) Worse BCVA at baseline predicted higher BCVA variation and greater likelihood of achieving a variation greater than 0 ETDRS letters, at 60 months. Dashed lined = fitted simple linear regression line. (b) Higher number of injections predicted greater likelihood of achieving a BCVA variation greater than 0 ETDRS letters, at 60 months. Dashed lined = fitted simple linear regression line. BCVA, best-corrected visual acuity; ETDRS, early treatment diabetic retinopathy study.

(a)

(b)